Charles G Drake, MD, PHD

Charles G. Drake, MD, PhD is a renowned physician-scientist located at 161 Fort Washington Avenue in New York, New York, United States. Dr. Drake's work focuses on understanding and combatting advanced-stage cancers using the immune system. He is known for quickly translating research discoveries into cutting-edge clinical trials, including the development of anti-tumor vaccines. His laboratory was the first to identify Lymphocyte Activation Gene-3 (LAG-3) as a marker for regulatory CD4 cells and to show that blocking LAG-3 can enhance anti-tumor immune responses. Dr. Drake's research has been published in prestigious journals and he has held positions at Johns Hopkins Kimmel Cancer Center. He is a professor of oncology, urology, and immunology, and has developed innovative models for studying prostate cancer. Dr. Drake earned his MD and PhD from top institutions and completed his medical training at Johns Hopkins Hospital. His work continues to push the boundaries of cancer treatment by exploring the intersection of immunotherapy and radiation therapy.